<DOC>
	<DOC>NCT00922181</DOC>
	<brief_summary>Microwave ablation (MWA) is the most recent development in the field of local ablative therapies. The aim of this study was to evaluate the variability and reproducibility of single-probe MWA versus radiofrequency ablation (RFA) of metastatic liver tumours smaller than 3 cm in patients without underlying liver disease.</brief_summary>
	<brief_title>Single-probe Microwave Ablation (MWA) of Metastatic Liver Cancer</brief_title>
	<detailed_description />
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>Unresectable metastatic liver cancer No invasion of major biliary structures No invasion of major vascular structures ASA score &lt; 4 WHO score 01 Preoperative chemotherapy is allowed Resectable liver metastases Life expectancy less than 3 months Patients with cardiac pacemaker, cerebral aneurysm clips, implanted electronic instruments or other metal materials Coagulopathy with platelet count less than 50000 Active infectious disease Age below 18 years Pregnancy of breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>malignancy</keyword>
	<keyword>liver</keyword>
	<keyword>microwave</keyword>
	<keyword>surgery</keyword>
</DOC>